Factors Associated with Medication Adherence among Type 2 Diabetes Mellitus Patients in Nepal

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 709-P
Author(s):  
PUSHPANJALI SHAKYA ◽  
BIRAJ M. KARMACHARYA ◽  
ARCHANA SHRESTHA ◽  
BAARD E. KULSENG
2017 ◽  
Vol 9 (1) ◽  
pp. 3-14 ◽  
Author(s):  
Mahmoud Radwan ◽  
Aymen Elsous ◽  
Hasnaa Al-Sharif ◽  
Ayman Abu Mustafa

Aim: In this study, we aimed to assess the level of good glycemic control, to determine association between adherence to antidiabetic medications and glycosylated hemoglobin (HbA1c) and to examine factors influencing good glycemic control. Materials and methods: A cross-sectional design was employed among 369 patients with type 2 diabetes mellitus (T2DM) from four Ministry of Health health centers in 2016. A sample of 3 ml blood was taken to measure the HbA1c, and patients were asked to fill out a pretested questionnaire. Univariate and multivariate logistic regressions, to identify independent factors associated with good glycemic control, were conducted using SPSS software version 22 (IBM Corp, Armonk, NY, USA). Results: Mean [±standard deviation (SD)] of HbA1c was 8.97 (2.02) and one fifth of patients had good glycemic control (HbA1c ⩽ 7%). Factors associated with good glycemic control were: older age [odds ratio (OR) = 0.96, 95% confidence interval (CI): 0.933–0.988), high medication adherence (OR: 2.757, 95% CI: 1.308–4.693), and better health literacy (OR= 2.124, 95% CI: 1.917–4.921). Duration of diabetes mellitus (DM > 7 years) was inversely related to good glycemic control (OR = 2.255, 95% CI: 1.189–4.276). Conclusion: Our study showed that glycemic control was suboptimal, and factors associated with that were: older age, high medication adherence, and better health literacy. Knowledge of these factors could be an entry toward helping patients and targeting interventions to improve glycemic control and prevent diabetes-related complications.


2021 ◽  
Author(s):  
Sheikh Mohammed Shariful Islam ◽  
Md. Tauhidul Islam ◽  
Riaz Uddin ◽  
Tania Tansi ◽  
Shamim Talukder ◽  
...  

2013 ◽  
Vol 29 (10) ◽  
pp. 1275-1286 ◽  
Author(s):  
Suellen M. Curkendall ◽  
Nina Thomas ◽  
Kelly F. Bell ◽  
Paul L. Juneau ◽  
Audrey J. Weiss

Author(s):  
Abdullah Alsabaani ◽  
Ahmed Mahfouz ◽  
Nabil Awadalla ◽  
Mustafa Musa ◽  
Suliman Al Humayed

The objective of this study was to determine the prevalence and the factors associated with non-alcoholic fatty liver disease (NAFLD) among type-2 diabetes mellitus (T2DM) patients in Abha City, Southwestern Saudi Arabia. Using a cross-sectional study design, a representative sample of 245 T2DM patients were recruited from all primary healthcare centers in Abha city. A detailed medical history as well as laboratory investigations were done. NAFLD was diagnosed using abdominal ultrasound examination. The overall prevalence of NAFLD was 72.8% (95% CI: 66.6%–78.1%). In a multivariable regression analysis, the risk of NAFLD was significantly higher among overweight T2DM patients (aOR = 6.112, 95% CI: 1.529–4.432), Obese (aOR = 10.455, 95% CI: 2.645–41.326), with high ALT of more than 12 IU/L (aOR = 2.335, 95% CI: 1.096–5.062), moderate diet-compliant patients (aOR = 2.413, 95% CI: 1.003–5.805) and poor diet-compliant patients (aOR = 6.562, 95% CI: 2.056–20.967). On the other hand, high HDL (high density cholesterol) (in mg/dL) was a protective factor for NAFLD (aOR = 0.044, 95% CI: 0.005–0.365). It was concluded that NAFLD is a common association of T2DM. Increasing BMI (Body mass index), lower HDL level, and poor dietary control are significant factors associated with NAFLD among T2DM patients. Health education to improve dietary control and avoid excessive weight gain, testing for NAFLD among diabetic patients, especially those with abnormal BMI and HDL, are recommended for early detection and to ensure optimal levels of HDL.


Sign in / Sign up

Export Citation Format

Share Document